Emphysema treatment focuses on slowing the disease, relieving breathlessness, and preventing flare-ups, since the lung damage itself cannot be reversed. The approach typically starts with lifestyle changes and inhaled medications, then layers on oxygen therapy, rehabilitation, or surgery as the disease progresses. What works best depends on how severe your symptoms are and how much lung function you’ve lost.
Quitting Smoking Has the Largest Single Effect
If you still smoke, stopping is the most impactful treatment available. Continuing smokers lose lung function at a rate more than 10 milliliters per year faster than people who have never smoked. That gap is dose-related: each additional cigarette per day accelerates the decline by roughly 0.33 mL per year. People who quit see their rate of decline drop to nearly the same level as never-smokers, a difference of about 12 mL per year compared to those who keep smoking. Over a decade, that adds up to a meaningful amount of preserved breathing capacity.
Quitting won’t restore tissue that’s already been destroyed, but it effectively puts the brakes on the process that’s destroying more. Nicotine replacement, prescription medications, and behavioral counseling all improve the odds of successfully stopping. For someone with emphysema, this single change does more to extend life and slow disability than any medication or procedure.
Inhaled Medications to Open the Airways
The core drug treatment for emphysema is inhaled bronchodilators, medications that relax the muscles around your airways so air flows more freely. These come in two main families, and most people with moderate to severe emphysema end up using one from each.
The first family works by stimulating receptors in the airway muscles to relax them. Short-acting versions like albuterol kick in within minutes and last four to six hours, making them useful as rescue inhalers when you’re suddenly short of breath. Long-acting versions are taken on a daily schedule to keep airways open around the clock. Some are inhaled twice a day, while newer options only need to be used once daily.
The second family blocks a nerve signal that causes airways to tighten. The short-acting form, ipratropium, is typically inhaled four times a day. Long-acting versions last 12 to 24 hours and are taken once or twice daily. These tend to be especially effective in emphysema because they also reduce mucus production.
Many people use a combination inhaler that contains one medication from each family in a single device, which simplifies the routine and often works better than either drug alone. Your doctor may also add an inhaled corticosteroid if you have frequent flare-ups, though steroids alone aren’t a first-line treatment for emphysema the way they are for asthma.
Pulmonary Rehabilitation
Pulmonary rehabilitation is a structured exercise and education program, typically two or three sessions per week over several weeks or months. The exercise component targets the muscles in your back, arms, and legs, along with the muscles you use to breathe. Strengthening these muscles helps you do more with the lung capacity you have left.
Sessions also cover breathing techniques, energy conservation strategies, and nutrition. The goal isn’t to reverse lung damage but to reduce the feeling of breathlessness during daily activities, build endurance, and help you manage flare-ups with less panic. For many people, rehab improves quality of life more noticeably than adding another inhaler.
Supplemental Oxygen
Not everyone with emphysema needs oxygen. It’s prescribed when blood oxygen levels drop below specific thresholds measured during a period of clinical stability. The standard cutoff is a blood oxygen saturation of 88% or lower at rest. If you have complications like strain on the right side of the heart, the threshold is slightly higher, at 89% or below.
Long-term oxygen therapy in people who meet these criteria has been shown to improve survival. It’s typically used for at least 15 hours a day, including during sleep. Portable concentrators and lightweight tanks make it possible to stay mobile, though many people resist starting oxygen because they associate it with being housebound. In practice, it often allows more activity because you’re no longer limited by dangerously low oxygen levels.
Vaccinations to Prevent Flare-Ups
Respiratory infections are a major trigger for emphysema exacerbations, those episodes where breathing suddenly worsens and may require hospitalization. Staying current on vaccines is a straightforward way to reduce that risk. The CDC recommends an annual flu shot, an RSV vaccine (administered seasonally), and keeping up with tetanus-pertussis boosters every 10 years for adults with chronic lung disease. Pneumococcal vaccines are also part of the standard schedule for this group.
Nutrition and Body Weight
Emphysema increases the energy cost of breathing. The muscles involved in respiration work harder, and many people with advanced disease burn significantly more calories just sitting still. Unintended weight loss is common and dangerous: losing muscle mass, particularly in the respiratory muscles, accelerates disability.
Energy requirements for maintaining weight in someone with emphysema run about 30 calories per kilogram of body weight per day. For a 150-pound person, that’s roughly 2,040 calories daily just to hold steady. If weight has already been lost, the target jumps to around 45 calories per kilogram per day to regain it. Protein needs are also elevated. People with chronic lung disease who are malnourished benefit from 1.2 to 1.5 grams of protein per kilogram of body weight daily, compared to the 0.8 grams recommended for healthy adults. A weight gain of at least 2 kilograms (about 4.4 pounds) is a meaningful therapeutic target that has been linked to improved outcomes.
Eating smaller, more frequent meals can help, since a full stomach pushes up against the diaphragm and makes breathing harder. High-calorie, nutrient-dense foods like nuts, avocados, eggs, and full-fat dairy can boost intake without requiring large volumes of food.
Lung Volume Reduction
In emphysema, destroyed portions of the lung trap air and overinflate, crowding out healthier tissue and flattening the diaphragm so it can’t contract effectively. Lung volume reduction removes or deflates these damaged sections, giving the remaining lung more room to work.
Surgical Lung Volume Reduction
This is a major operation, typically considered for people whose lung function (measured by a breathing test called FEV1) falls between 20% and 45% of what’s predicted for their age and size. Candidates also need adequate gas exchange capacity; people with very low diffusion capacity (below 20% of predicted) are generally excluded because the surgical risk is too high. The best results occur when the damage is concentrated in the upper portions of the lungs, leaving healthier tissue below to expand after surgery.
Endobronchial Valves
A less invasive alternative uses tiny one-way valves placed into the airways during a bronchoscopy, a procedure done through a scope passed down the throat. The valves block air from entering the most damaged sections of lung, causing them to deflate. This gives healthier areas room to expand, much like the surgical approach but without chest incisions.
Clinical trials have shown meaningful improvements. Across four randomized controlled trials, people who received valves saw their lung function improve by 17% to 29% more than control groups, along with better exercise capacity and quality of life. The procedure works best when there’s no air leaking between lung segments through small channels (called collateral ventilation), which is tested beforehand. The most common complication is a collapsed lung shortly after the procedure, which usually resolves with a chest tube.
Lung Transplantation
Transplantation is reserved for people with the most severe disease who continue to decline despite all other treatments. Referral to a transplant center is recommended when FEV1 drops below 25% of predicted, when carbon dioxide levels in the blood rise above 50 mmHg, or when oxygen levels fall below 60 mmHg despite therapy.
A scoring system called the BODE index, which combines body mass, airflow obstruction, breathlessness, and exercise capacity into a single number from 0 to 10, helps guide timing. A score of 5 or 6 typically triggers referral to a transplant center, while a score of 7 or higher suggests it’s time for formal listing. Patients who have had three or more exacerbations requiring hospitalization, or even a single episode that caused respiratory failure requiring mechanical ventilation, may also be listed.
Transplantation can dramatically improve breathing and quality of life, but it comes with lifelong immunosuppression and the risk of organ rejection. The median survival after lung transplant for emphysema is roughly five to six years, though some recipients live much longer. It’s not a cure so much as a trade of one set of medical challenges for another, one that makes sense when the alternative is continued decline.